Nat. Med. 11, 71–76 (2005)
In Fig. 2a, the second and fourth graphs in the lower row should be marked Tnfrsf10b and Tnfrsf6, respectively. In Fig. 2b, the gene symbol Tp53 should read Tp53−/−.
In Methods, the administration of VPA and TSA for in vivo antitumor activity studies should be “intraperitoneally for 21 d at a dose of 400 mg/kg twice daily and 1 mg/kg/d, respectively.”
Additional information
The online version of the original article can be found at 10.1038/nm1160
Rights and permissions
About this article
Cite this article
Insinga, A., Monestiroli, S., Ronzoni, S. et al. Erratum: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med 11, 233 (2005). https://doi.org/10.1038/nm0205-233a
Issue Date:
DOI: https://doi.org/10.1038/nm0205-233a
